PROTAC CYP1B1 Degrader-1, a derivative of α-naphthoflavone, is designed to selectively degrade CYP1B1, reducing cytochrome P450-mediated resistance. Its structure effectively targets CYP1B1 while showing selectivity over CYP1A2, making it useful for studying CYP1B1-overexpressing systems.
Usually ships within 24 hours.